A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma

Targeting the epidermal growth factor receptor (EGFR) is one of the potential ways to treat glioblastoma (GBM). In this study, we investigate the anti-GBM tumor effects of the EGFR inhibitor SMUZ106 in both in vitro and in vivo conditions. The effects of SMUZ106 on the growth and proliferation of GB...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ying, Huang, Chunhui, Huang, Yaqi, Long, Lifan, Wu, Guowu, Guo, Fengqiu, Huang, Chuan, Liu, Siming, Zhu, Zhengguang, Wu, Shaoyu, Li, Zhonghuang, Zhang, Jiajie, Wan, Shanhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220892/
https://www.ncbi.nlm.nih.gov/pubmed/37242743
http://dx.doi.org/10.3390/pharmaceutics15051501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220892/
https://www.ncbi.nlm.nih.gov/pubmed/37242743
http://dx.doi.org/10.3390/pharmaceutics15051501

Ejemplares similares